Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Tzvi Palash joins Protalix BioTherapeutics

September 9, 2010 Manufacturing and Production, Research and Development Portalix BioTherapeutics, appointment, manufacturing and production, research and development

Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
Appointment
Andreotti

BMS to acquire ZymoGenetics

September 8, 2010 Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
News
Dr Meena Jain

Working Life: Dr Meena Jain

September 8, 2010 Business Services, Research and Development Napp, Working Life, careers, recruitment

How did you find your way into your most current role? I’ve been at Napp for four years now having …
Feature

GSK patient recruitment head joins Exco InTouch

September 8, 2010 Research and Development Exco InTouch, appointment, research and development

Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …
Appointment

Pfizer drops brain cancer vaccine

September 7, 2010 Research and Development Celldex Therapeutics, Pfizer, cancer vaccine

Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …
News

Roche signs Alzheimer’s deal with reMYND

September 7, 2010 Research and Development Alzheimer's, Parkinson's, Roche, reMYND

Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
News

Merck averts day in court over Dutch plant closure

September 7, 2010 Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts

Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …
News

Next generation Malaria drug shows promise

September 6, 2010 Research and Development malaria

A Novartis-led collaboration has discovered a novel anti-malarial candidate that could become the first new treatment for the disease in …
News

Pradaxa, Xarelto and apixaban vie for attention

September 6, 2010 Research and Development, Sales and Marketing Pradaxa, Xarelto, apixaban, atrial fibrilation

New data has intensified the competition between three rival would-be cardiology blockbusters. Boehringer Ingelheim’s Pradaxa (dabigatran) and Bayer’s Xarelto (rivaroxaban) …
News
Roche building

Roche set for jobs cuts from 2011

September 3, 2010 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, job cuts

Roche has confirmed it will take wide-ranging steps to reduce costs, following local reports the Swiss pharma firm was poised …
News

UK biotech body elects new chairman

September 3, 2010 Research and Development BIA, appointment, research and development

Cellzome’s president and chief executive Tim Edwards has been elected chairman of the BioIndustry Association. Commenting on his election he …
Appointment

Contract research news in brief

September 3, 2010 Research and Development Cyprotex, Epistem, INC Research, Jubilant, Laxal Pharma

A round-up of recent news from the CRO sector, featuring updates from Cyprotex, INC Research, Laxai Pharma, Asuragen, Jubilant Organosys …
News
Nigel Brooksby

Nigel Brooksby joins Prism Ideas

September 2, 2010 Medical Communications, Research and Development Prism Ideas, appointment, medical communications, research and development

Former Sanofi-Aventis UK chairman and managing director Nigel Brooksby has joined Cheshire, UK-based Prism Ideas as non-executive chairman. The medical …
Appointment

Genzyme available for ‘fair value’, says Termeer

September 2, 2010 Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …
News

Pfizer acquires ‘protein misfolding’ specialist

September 2, 2010 Research and Development FoldRx, Pfizer, cystic fibrosis

Pfizer has bolstered its presence in rare and orphan diseases with the acquisition of FoldRx, a US drug discovery firm …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026